Correlation Between Bio Gene and FleetPartners

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bio Gene and FleetPartners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Gene and FleetPartners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Gene Technology and FleetPartners Group, you can compare the effects of market volatilities on Bio Gene and FleetPartners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Gene with a short position of FleetPartners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Gene and FleetPartners.

Diversification Opportunities for Bio Gene and FleetPartners

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Bio and FleetPartners is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Bio Gene Technology and FleetPartners Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FleetPartners Group and Bio Gene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Gene Technology are associated (or correlated) with FleetPartners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FleetPartners Group has no effect on the direction of Bio Gene i.e., Bio Gene and FleetPartners go up and down completely randomly.

Pair Corralation between Bio Gene and FleetPartners

Assuming the 90 days trading horizon Bio Gene Technology is expected to under-perform the FleetPartners. In addition to that, Bio Gene is 2.72 times more volatile than FleetPartners Group. It trades about -0.01 of its total potential returns per unit of risk. FleetPartners Group is currently generating about 0.06 per unit of volatility. If you would invest  225.00  in FleetPartners Group on September 2, 2024 and sell it today you would earn a total of  92.00  from holding FleetPartners Group or generate 40.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Bio Gene Technology  vs.  FleetPartners Group

 Performance 
       Timeline  
Bio Gene Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bio Gene Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Bio Gene is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
FleetPartners Group 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in FleetPartners Group are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, FleetPartners is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Bio Gene and FleetPartners Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bio Gene and FleetPartners

The main advantage of trading using opposite Bio Gene and FleetPartners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Gene position performs unexpectedly, FleetPartners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FleetPartners will offset losses from the drop in FleetPartners' long position.
The idea behind Bio Gene Technology and FleetPartners Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device